TY - JOUR JF - Respiratory Research UR - https://archiv.ub.uni-heidelberg.de/volltextserver/20816/ CY - London A1 - Harzheim, Dominik A1 - Klose, Hans A1 - Pinado, Fabiola Peña A1 - Ehlken, Nicola A1 - Nagel, Christian A1 - Fischer, Christine A1 - Ghofrani, Ardeschir A1 - Rosenkranz, Stephan A1 - Seyfarth, Hans-Jürgen A1 - Halank, Michael A1 - Mayer, Eckhard A1 - Grünig, Ekkehard A1 - Guth, Stefan N2 - Background: The objective of this prospective study was to assess the prevalence of anxiety and depression disorders and their association with quality of life (QoL), clinical parameters and survival in patients with pulmonary hypertension (PH). Methods: We prospectively assessed 158 patients invasively diagnosed with pulmonary arterial hypertension (n = 138) and inoperable chronic thromboembolic PH (n = 20) by clinical measures including quality of life (QoL, SF-36 questionnaire), cardiopulmonary exercise testing and six minute walking distance and by questionnaires for depression (PHQ-9) and anxiety (GAD-7). According to the results of the clinical examination and the questionnaires for mental disorders (MD) patients were classified into two groups, 1) with moderate to severe MD (n = 36, 22,8%), and 2) with mild or no MD (n = 122). Patients were followed for a median of 2.7 years. Investigators of QoL, SF-36 were blinded to the clinical data. Results: At baseline the 2 groups did not differ in their severity of PH or exercise capacity. Patients with moderate to severe MD (group 1) had a significantly lower QoL shown in all subscales of SF-36 (p < 0.002). QoL impairment significantly correlated with the severity of depression (p < 0.001) and anxiety (p < 0.05). During follow-up period 32 patients died and 3 were lost to follow-up. There was no significant difference between groups regarding survival. Only 8% of the patients with MD received psychopharmacological treatment. Conclusion: Anxiety and depression were frequently diagnosed in our patients and significantly correlated with quality of life, but not with long term survival. Further prospective studies are needed to confirm the results. PB - BioMed Central EP - 10 TI - Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension IS - 104 SP - 1 AV - public SN - 1465-993X Y1 - 2013/// ID - heidok20816 VL - 14 ER -